Geode Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Sell |
1,925,573
-51,764
| -3% | -$186K | ﹤0.01% | 2561 |
|
|
2025
Q1 | $5.91M | Buy |
1,977,337
+60,551
| +3% | +$181K | ﹤0.01% | 2582 |
|
|
2024
Q4 | $6.42M | Sell |
1,916,786
-7,987
| -0.4% | -$26.8K | ﹤0.01% | 2622 |
|
|
2024
Q3 | $6.45M | Sell |
1,924,773
-85,030
| -4% | -$285K | ﹤0.01% | 2626 |
|
|
2024
Q2 | $6.65M | Buy |
2,009,803
+127,323
| +7% | +$421K | ﹤0.01% | 2577 |
|
|
2024
Q1 | $7.61M | Buy |
1,882,480
+74,568
| +4% | +$301K | ﹤0.01% | 2489 |
|
|
2023
Q4 | $5.51M | Buy |
1,807,912
+82,183
| +5% | +$251K | ﹤0.01% | 2651 |
|
|
2023
Q3 | $5.18M | Buy |
1,725,729
+80,691
| +5% | +$242K | ﹤0.01% | 2619 |
|
|
2023
Q2 | $6.15M | Buy |
1,645,038
+154,974
| +10% | +$580K | ﹤0.01% | 2580 |
|
|
2023
Q1 | $4.99M | Buy |
1,490,064
+52,705
| +4% | +$177K | ﹤0.01% | 2626 |
|
|
2022
Q4 | $6.91M | Buy |
1,437,359
+48,156
| +3% | +$232K | ﹤0.01% | 2481 |
|
|
2022
Q3 | $7.9M | Buy |
1,389,203
+227,779
| +20% | +$1.3M | ﹤0.01% | 2404 |
|
|
2022
Q2 | $8.25M | Buy |
1,161,424
+132,664
| +13% | +$942K | ﹤0.01% | 2386 |
|
|
2022
Q1 | $7.43M | Sell |
1,028,760
-52,033
| -5% | -$376K | ﹤0.01% | 2554 |
|
|
2021
Q4 | $9.66M | Buy |
1,080,793
+48,197
| +5% | +$431K | ﹤0.01% | 2464 |
|
|
2021
Q3 | $36.2M | Buy |
1,032,596
+355,543
| +53% | +$12.5M | ﹤0.01% | 1544 |
|
|
2021
Q2 | $14.5M | Buy |
677,053
+402,168
| +146% | +$8.64M | ﹤0.01% | 2198 |
|
|
2021
Q1 | $17M | Buy |
274,885
+7,019
| +3% | +$433K | ﹤0.01% | 1982 |
|
|
2020
Q4 | $11.2M | Buy |
+267,866
| New | +$11.2M | ﹤0.01% | 2094 |
|